| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/15/2002 | CA2094726C Non-chlorofluorocarbon aerosol formulation comprising a particulate medicament |
| 01/10/2002 | WO2002002775A2 Calpain protease 12 |
| 01/10/2002 | WO2002002773A2 Dual specificity antibodies and methods of making and using |
| 01/10/2002 | WO2002002770A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/10/2002 | WO2002002767A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/10/2002 | WO2002002755A2 Regulation of human thimet oligopeptidase-like enzyme |
| 01/10/2002 | WO2002002640A2 Antibodies to human mcp-1 |
| 01/10/2002 | WO2002002638A2 Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 01/10/2002 | WO2002002634A2 Human extracellular matrix and cell adhesion polypeptides |
| 01/10/2002 | WO2002002633A2 Transporters and ion channels |
| 01/10/2002 | WO2002002629A2 Grf2-binding proteins and applications thereof |
| 01/10/2002 | WO2002002625A2 Novel fibroblast growth factors and nucleic acids encoding same |
| 01/10/2002 | WO2002002610A2 Secretion and trafficking molecules |
| 01/10/2002 | WO2002002603A2 Protein modification and maintenance molecules |
| 01/10/2002 | WO2002002593A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
| 01/10/2002 | WO2002002587A1 B7-like polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | WO2002002567A1 Thienopyrrolidinones |
| 01/10/2002 | WO2002002566A1 Therapeutic compounds and methods |
| 01/10/2002 | WO2002002565A2 Glucocortiocoid-selective antiinflammatory agents |
| 01/10/2002 | WO2002002564A1 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 01/10/2002 | WO2002002556A2 AZA-BRIDGED-BICYCLIC AMINO ACID DERIVATIVES AS α4 INTEGRIN ANTAGONISTS |
| 01/10/2002 | WO2002002551A1 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
| 01/10/2002 | WO2002002549A1 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 01/10/2002 | WO2002002547A1 Pyrones as inhibitors of cyclooxygenase-2 |
| 01/10/2002 | WO2002002542A1 Five-membered-ring compound |
| 01/10/2002 | WO2002002541A2 Inhibitors of copper-containing amine oxidases |
| 01/10/2002 | WO2002002539A1 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 01/10/2002 | WO2002002525A2 N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity |
| 01/10/2002 | WO2002002522A1 Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 01/10/2002 | WO2002002511A1 Substituted benzamides for immune enhancement and for the treatment of cancer, infection and manic-depressive illness |
| 01/10/2002 | WO2002002140A1 Vaccine comprising active agent immunogenic acyl glyceryl phosphatidylinositol manno-oligosaccharide |
| 01/10/2002 | WO2002002132A1 Chemokine conjugates |
| 01/10/2002 | WO2002002118A1 Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies |
| 01/10/2002 | WO2002002111A1 Dermal therapeutic system containing non-steroidal antiphlogistics with selective cox-2 inhibition |
| 01/10/2002 | WO2002002109A1 Use of galiella lactone |
| 01/10/2002 | WO2002002096A2 Oral compositions comprising host-response modulating agent |
| 01/10/2002 | WO2002002095A2 Compositions for treating bacterial infections containing oxazolidinone compound, sulbactam and an ampicillin |
| 01/10/2002 | WO2002002090A2 Inhibitors of copper-containing amine oxidases |
| 01/10/2002 | WO2002002011A1 Dna encoding human serine protease d-g |
| 01/10/2002 | WO2002001969A1 Vitamin k and essential fatty acids |
| 01/10/2002 | WO2001059071A3 Methods of preparing and using a viral vector library |
| 01/10/2002 | WO2001043691A3 Fragments and antagonists of heat shock protein 60 |
| 01/10/2002 | WO2001036425A3 Imidazole compounds used as phosphodiesterase vii inhibitors |
| 01/10/2002 | WO2001021191A3 Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs |
| 01/10/2002 | WO2000055332A3 Human regulators of intracellular phosphorylation |
| 01/10/2002 | US20020004608 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 01/10/2002 | US20020004585 Antibody for use in the detection of preferential enzyme expression; for use as tool in treatment and detection of enzyme defects; for treatment autoimmune disease, inflammation, sepsis, diabetes, kidney defects and cancer |
| 01/10/2002 | US20020004532 Low emulsifier multiple emulsions |
| 01/10/2002 | US20020004508 Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 01/10/2002 | US20020004497 Combination injection preparation |
| 01/10/2002 | US20020004492 Polypeptides; wound healing agent, antiinflammatory agent |
| 01/10/2002 | US20020004489 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | US20020004218 Bone disorders therapy |
| 01/10/2002 | US20020004049 Tryptophan source from plants and uses therfor |
| 01/10/2002 | US20020004032 Macrocyclic chelants for metallopharmaceuticals |
| 01/10/2002 | DE10031932A1 Calpain-Protease 12 Calpain protease 12 |
| 01/10/2002 | DE10031585A1 2-Aminoalkyl-thieno[2,3-d]pyrimidine 2-aminoalkyl-thieno [2,3-d] pyrimidines |
| 01/10/2002 | DE10030345A1 Hochkonzentrierte stabile Meloxicamlösungen Highly concentrated stable meloxicam |
| 01/10/2002 | CA2630062A1 Methods for treating graft versus host disease and immune disorders associated with rejection using a soluble ctla4 molecule |
| 01/10/2002 | CA2415123A1 Novel fibroblast growth factors and nucleic acids encoding same |
| 01/10/2002 | CA2415088A1 Aza-bridged-bicyclic amino acid derivatives as .alpha.4 integrin antagonists |
| 01/10/2002 | CA2415037A1 Glucocortiocoid-selective antiinflammatory agents |
| 01/10/2002 | CA2414807A1 Inhibitors of copper-containing amine oxidases |
| 01/10/2002 | CA2414799A1 Inhibitors of copper-containing amine oxidases |
| 01/10/2002 | CA2414705A1 Thienopyrrolidinones |
| 01/10/2002 | CA2414660A1 Use of galiella lactone |
| 01/10/2002 | CA2414592A1 Calpain protease 12 |
| 01/10/2002 | CA2414468A1 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
| 01/10/2002 | CA2414464A1 Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 01/10/2002 | CA2414461A1 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 01/10/2002 | CA2414352A1 Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies |
| 01/10/2002 | CA2414347A1 Vaccine comprising active agent immunogenic acyl glyceryl phosphatidylinositol manno-oligosaccharide |
| 01/10/2002 | CA2413756A1 Dna encoding human serine protease d-g |
| 01/10/2002 | CA2413715A1 Grf2-binding proteins and applications thereof |
| 01/10/2002 | CA2413245A1 N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity |
| 01/10/2002 | CA2413186A1 Extracellular matrix and cell adhesion molecules |
| 01/10/2002 | CA2413128A1 Transporters and ion channels |
| 01/10/2002 | CA2412874A1 Pyrones as inhibitors of cyclooxygenase-2 |
| 01/10/2002 | CA2412872A1 Protein modification and maintenance molecules |
| 01/10/2002 | CA2412775A1 Antibodies to human mcp-1 |
| 01/10/2002 | CA2412620A1 Vitamin k and essential fatty acids |
| 01/10/2002 | CA2412287A1 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 01/10/2002 | CA2410945A1 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 01/10/2002 | CA2410679A1 Secretion and trafficking molecules |
| 01/10/2002 | CA2406649A1 B7-like polynucleotides, polypeptides, and antibodies |
| 01/09/2002 | EP1170594A2 Methods for the identification of compounds useful for the treatment of disease states mediated by Prostaglandin D2 |
| 01/09/2002 | EP1170281A1 1,1- and 1,2-disubstituted cyclopropanes, process for their preparation and pharmaceutical compositions thereof |
| 01/09/2002 | EP1170020A1 Patches for external use |
| 01/09/2002 | EP1170017A1 Use of tumor necrosis factor alpha (TNF-alpha) and vascular endothelial growth factor (VEGF) for the manufacture of a therapeutic composition |
| 01/09/2002 | EP1170009A2 Thiazolybenzofuran derivatives and their use as SRS-A and leukotiene antagonists |
| 01/09/2002 | EP1169469A1 Human colon cancer associated gene sequences and polypeptides |
| 01/09/2002 | EP1169448A1 Tumor necrosis factor homologs and nucleic acids encoding the same |
| 01/09/2002 | EP1169445A2 Human proteins and polynucleotides encoding them |
| 01/09/2002 | EP1169442A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2002 | EP1169440A1 48 human secreted proteins |
| 01/09/2002 | EP1169348A1 Purposeful movement of human migratory cells away from an agent source |
| 01/09/2002 | EP1169346A1 48 human secreted proteins |
| 01/09/2002 | EP1169344A1 47 human secreted proteins |
| 01/09/2002 | EP1169338A2 Low-molecular inhibitors of complement proteases |
| 01/09/2002 | EP1169337A2 Steroid nitrates for the treatment of oxidative injury and endothelial dysfunction |